Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.
about
Vaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in useRotavirus vaccines in routine useVaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirusPredominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination.Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq.Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of SpainDynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.Impact of rotavirus vaccination in Australian children below 5 years of age: a database study.Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.Current status of rotavirus vaccines.Re-evaluation of the cost-effectiveness and effects of childhood rotavirus vaccination in Norway.Full genome analysis of rotavirus G9P[8] strains identified in acute gastroenteritis cases reveals genetic diversity: Pune, western India.Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.Economic evaluation of routine infant rotavirus immunisation program in Japan.Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.Rotavirus vaccination and infection induce VP6-specific IgA responses.Rotavirus vaccines: safety, efficacy and public health impact.Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC).Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in BrazilUpdated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting
P2860
Q24197495-94B33298-0120-426B-A651-47E50BB9CC1BQ24203645-02E78253-12E2-4554-811F-68998573C5D7Q26853690-E1D9C0F0-C66E-4C0F-8F0D-307254B625B6Q26995690-F47FDB89-CA5F-4B89-9EB5-D3ACDB9AE2CAQ33646176-DD824A7C-BD81-45D8-9345-53DB2CDDC75FQ33929557-89FDAB64-2AA7-410A-A7A4-7B8B06C28FCBQ34690736-3948D5B5-8AD8-4C09-BF85-F51AAC388C45Q35806976-D85D67E7-546E-4400-89C4-B34D86FBF791Q37130786-214A8F2E-11B8-49B7-B059-3F42FAEC715CQ37448980-2FAC7381-91A1-41D6-A7E0-80D13F7BD58AQ37530039-CE9664BD-DC08-4E4A-9265-DEED1F6CE4F4Q37981766-5A856C28-8612-491D-BAFD-43E6C715F3C6Q38603768-F5FD0595-6BF6-47C3-A46D-07C319875104Q38619905-F595EE9D-76F3-4EC0-971B-2C446B132256Q40317202-BB21A695-9908-4AD8-9BEC-840CAB37A8B2Q40451693-A926F234-A80F-4917-AD51-45C19754562AQ40496831-4ADA270B-FA63-4908-81D8-74FC9DFF4E02Q40530316-67134EF9-674A-4560-9F00-C987D52FFF72Q40608783-7434EB0D-E664-450B-9F0B-2CA05FD7E0CCQ45165657-4DE35409-0BB5-4FC4-A809-1642E9C80F27Q47422430-1EC6E25B-868C-40DE-A11F-F67706D98175Q48167285-1D8C6C31-7EE9-4E6B-91AE-8B8DAFD67004Q50876164-28449B92-2D82-4D9B-9206-B84A21633EBAQ58232513-BF9C8E9B-8E39-4845-8760-C9BB783C7229Q58756646-31B16780-4146-4F79-AAD4-7E6801D6AC22
P2860
Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@ast
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@en
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@nl
type
label
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@ast
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@en
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@nl
prefLabel
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@ast
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@en
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@nl
P2093
P2860
P1476
Efficacy of the pentavalent ro ...... : the Finnish Extension Study.
@en
P2093
Aino Karvonen
Shannon Allen Ferrante
Timo Vesikari
P2860
P2888
P304
P356
10.1007/S00431-010-1242-3
P50
P577
2010-06-18T00:00:00Z
P5875
P6179
1011885303